Eysuvis (loteprednol etabonate) NDC 71571-333

NDC codes

FDA NDC Directory

Product NDC (as listed)71571-333Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71571-0333Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71571-333-01	71571033301	1 BOTTLE, DROPPER in 1 CARTON (71571-333-01) / 1 mL in 1 BOTTLE, DROPPERMarketed from Dec 14, 2023 · Sample package
71571-333-24	71571033324	2.4 mL in 1 BOTTLE, DROPPER (71571-333-24)Marketed from Nov 18, 2020 · Sample package
71571-333-83	71571033383	1 BOTTLE, DROPPER in 1 CARTON (71571-333-83) / 8.3 mL in 1 BOTTLE, DROPPERMarketed from Nov 18, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Eysuvis
Generic name (nonproprietary): loteprednol etabonate
Active ingredients: Loteprednol etabonate — 2.5 mg/mL
Dosage form: Suspension/ drops
Route: Ophthalmic
Labeler: ALCON LABORATORIES, INC.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 210933
Marketing start: Nov 18, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 71571-333_db147c65-ed03-4af5-af1f-86b9ff51148aSPL ID db147c65-ed03-4af5-af1f-86b9ff51148aSPL set ID a2169d82-4275-4ab6-a1c3-c274080b815cRxCUI 2464838, 2464843UNII YEH1EZ96K6
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471571033301 followed by a unit qualifier and the quantity

Package 71571-0333-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 11, 2025.

Indications (excerpt from the label)

EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)